NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

UPDATE 1-Home Capital names new board member amid regulatory probe

Published 2017-05-05, 07:32 a/m
© Reuters.  UPDATE 1-Home Capital names new board member amid regulatory probe
EXE
-
HBM
-
HCG
-

(Adds details)

May 5 (Reuters) - Home Capital Group Inc HCG.TO named Alan Hibben to its board, replacing Gerald Soloway, who has been accused by regulators of making "materially misleading statements" to investors.

Soloway, one of the founders of the mortgage lending company, said last month he would step down from the board once a replacement was found. Capital said Hibben will be appointed to the board effective Friday and will stand for election at the company's upcoming annual meeting to be held next month in Toronto.

Hibben, who retired as a managing director from RBC Capital Markets in 2014, has been an adviser to the Province of Ontario on a number of files including the Companies' Creditors Arrangement Act (CCAA) processes for Stelco and Algoma Steel.

He also serves as a director on the boards of HudBay Minerals Inc HBM.TO , Extendicare Inc EXE.TO and the Mount Sinai Hospital Foundation.

"This is the start of our governance renewal," Kevin Smith, chairman of the board, said in a statement.

The Ontario Securities Commission (OSC) in April accused Canada's biggest non-bank mortgage lender of making "materially misleading statements" to investors and issued allegations against the company's former chief executives, Soloway and Martin Reid, and current Chief Financial Officer Robert Morton.

The company said it had made "considerable progress" in identifying new candidates for the board and for a new chief executive. The new CEO will in turn be involved in hiring the new chief financial officer, it said. who will resign from the board effective Friday, will not stand for re-election, Home Capital said. Last month, the company said he would contest elections to the board at the annual general meeting.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.